Scientists Just Found a Cholesterol Clue That Could Change Parkinson’s Treatment
A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the spread of harmful protein clumps in the brain. Researchers found that high levels of this metabolite accelerate neuron damage and motor dysfunction,
A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...
After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...
Experts from Huashan Hospital conduct Parkinson's disease research in a laboratory.
Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...
BOXING legend Mike Tyson has denied he is suffering from Parkinson’s disease – after a now-retracted claim from Jake Paul.
Donald Small Jr., who has Parkinson's disease, will spend at least a couple of years in a prison for fatally stabbing his ...
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month ...
Dr. Cheng's team continues to explore AI's potential in drug repurposing for neurodegenerative diseases. Their findings suggest that reducing cholesterol, glucose levels and blood pressure through ...
In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback